These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32744954)

  • 1. Falcipain-2 and Falcipain-3 Inhibitors as Promising Antimalarial Agents.
    Ettari R; Previti S; Di Chio C; Zappalà M
    Curr Med Chem; 2021; 28(15):3010-3031. PubMed ID: 32744954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Falcipain-2 inhibitors.
    Ettari R; Bova F; Zappalà M; Grasso S; Micale N
    Med Res Rev; 2010 Jan; 30(1):136-67. PubMed ID: 19526594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Falcipain inhibition as a promising antimalarial target.
    Marco M; Coterón JM
    Curr Top Med Chem; 2012; 12(5):408-44. PubMed ID: 22242849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of whole genome sequence data on drug discovery--a malaria case study.
    Joachimiak MP; Chang C; Rosenthal PJ; Cohen FE
    Mol Med; 2001 Oct; 7(10):698-710. PubMed ID: 11713369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimalarial activities of novel synthetic cysteine protease inhibitors.
    Lee BJ; Singh A; Chiang P; Kemp SJ; Goldman EA; Weinhouse MI; Vlasuk GP; Rosenthal PJ
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3810-4. PubMed ID: 14638488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteine proteases of malaria parasites.
    Rosenthal PJ
    Int J Parasitol; 2004 Dec; 34(13-14):1489-99. PubMed ID: 15582526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Falcipain cysteine proteases of malaria parasites: An update.
    Rosenthal PJ
    Biochim Biophys Acta Proteins Proteom; 2020 Mar; 1868(3):140362. PubMed ID: 31927030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of efficacies of cysteine protease inhibitors against five strains of Plasmodium falciparum.
    Singh A; Rosenthal PJ
    Antimicrob Agents Chemother; 2001 Mar; 45(3):949-51. PubMed ID: 11181388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Falcipains and other cysteine proteases of malaria parasites.
    Rosenthal PJ
    Adv Exp Med Biol; 2011; 712():30-48. PubMed ID: 21660657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prodomain peptide of Plasmodium falciparum cysteine protease (falcipain-2) inhibits malaria parasite development.
    Korde R; Bhardwaj A; Singh R; Srivastava A; Chauhan VS; Bhatnagar RK; Malhotra P
    J Med Chem; 2008 Jun; 51(11):3116-23. PubMed ID: 18461922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemoglobin cleavage site-specificity of the Plasmodium falciparum cysteine proteases falcipain-2 and falcipain-3.
    Subramanian S; Hardt M; Choe Y; Niles RK; Johansen EB; Legac J; Gut J; Kerr ID; Craik CS; Rosenthal PJ
    PLoS One; 2009; 4(4):e5156. PubMed ID: 19357776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors.
    Moura PA; Dame JB; Fidock DA
    Antimicrob Agents Chemother; 2009 Dec; 53(12):4968-78. PubMed ID: 19752273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Cysteine Proteases from Plasmodium falciparum: A General Overview, Rational Drug Design and Computational Approaches for Drug Discovery.
    Bekono BD; Ntie-Kang F; Owono Owono LC; Megnassan E
    Curr Drug Targets; 2018; 19(5):501-526. PubMed ID: 28003005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of cysteine protease inhibitor-resistant malaria parasites is accompanied by amplification of falcipain genes and alteration in inhibitor transport.
    Singh A; Rosenthal PJ
    J Biol Chem; 2004 Aug; 279(34):35236-41. PubMed ID: 15192087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships for inhibition of cysteine protease activity and development of Plasmodium falciparum by peptidyl vinyl sulfones.
    Shenai BR; Lee BJ; Alvarez-Hernandez A; Chong PY; Emal CD; Neitz RJ; Roush WR; Rosenthal PJ
    Antimicrob Agents Chemother; 2003 Jan; 47(1):154-60. PubMed ID: 12499184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary flavonoids fisetin and myricetin: dual inhibitors of Plasmodium falciparum falcipain-2 and plasmepsin II.
    Jin H; Xu Z; Cui K; Zhang T; Lu W; Huang J
    Fitoterapia; 2014 Apr; 94():55-61. PubMed ID: 24468190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3.
    Sijwali PS; Shenai BR; Gut J; Singh A; Rosenthal PJ
    Biochem J; 2001 Dec; 360(Pt 2):481-9. PubMed ID: 11716777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Falcipain inhibitors as potential therapeutics for resistant strains of malaria: a patent review.
    Mane UR; Gupta RC; Nadkarni SS; Giridhar RR; Naik PP; Yadav MR
    Expert Opin Ther Pat; 2013 Feb; 23(2):165-87. PubMed ID: 23228154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel class of falcipain-2 inhibitors as potential antimalarial agents.
    Chakka SK; Kalamuddin M; Sundararaman S; Wei L; Mundra S; Mahesh R; Malhotra P; Mohmmed A; Kotra LP
    Bioorg Med Chem; 2015 May; 23(9):2221-40. PubMed ID: 25840796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antimalarial effects of phenothiazine inhibitors of a Plasmodium falciparum cysteine protease.
    Domínguez JN; López S; Charris J; Iarruso L; Lobo G; Semenov A; Olson JE; Rosenthal PJ
    J Med Chem; 1997 Aug; 40(17):2726-32. PubMed ID: 9276017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.